These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 19513636

  • 21. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies.
    Racke MK.
    Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S9-S18. PubMed ID: 18388801
    [Abstract] [Full Text] [Related]

  • 22. Neuromyelitis optica and asian phenotype of multiple sclerosis.
    Kira J.
    Ann N Y Acad Sci; 2008 Oct; 1142():58-71. PubMed ID: 18990121
    [Abstract] [Full Text] [Related]

  • 23. Diagnostic modalities in multiple sclerosis: perspectives in children.
    Chou IJ, Whitehouse WP, Wang HS, Tanasescu R, Constantinescu CS.
    Biomed J; 2014 Oct; 37(2):50-9. PubMed ID: 24732659
    [Abstract] [Full Text] [Related]

  • 24. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H.
    Verh Dtsch Ges Pathol; 1996 Oct; 80():109-15. PubMed ID: 9064993
    [Abstract] [Full Text] [Related]

  • 25. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.
    Cayrol R, Saikali P, Vincent T.
    Ann N Y Acad Sci; 2009 Sep; 1173():478-86. PubMed ID: 19758189
    [Abstract] [Full Text] [Related]

  • 26. B cells and multiple sclerosis.
    Franciotta D, Salvetti M, Lolli F, Serafini B, Aloisi F.
    Lancet Neurol; 2008 Sep; 7(9):852-8. PubMed ID: 18703007
    [Abstract] [Full Text] [Related]

  • 27. Complexity and heterogeneity in demyelinating disease.
    Compston A.
    Brain; 2007 May; 130(Pt 5):1178-80. PubMed ID: 17472981
    [No Abstract] [Full Text] [Related]

  • 28. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
    Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B.
    Nat Clin Pract Neurol; 2008 Apr; 4(4):202-14. PubMed ID: 18334978
    [Abstract] [Full Text] [Related]

  • 29. The role of B cells and autoantibodies in multiple sclerosis.
    Archelos JJ, Storch MK, Hartung HP.
    Ann Neurol; 2000 Jun; 47(6):694-706. PubMed ID: 10852535
    [Abstract] [Full Text] [Related]

  • 30. Clinical and magnetic resonance imaging features of multiple sclerosis with autoreactive antibodies in Ishikawa Prefecture, Japan.
    Takahashi K, Tanaka K.
    J Neuroimmunol; 2012 Sep 15; 250(1-2):111-4. PubMed ID: 22705464
    [Abstract] [Full Text] [Related]

  • 31. The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders.
    Häusser-Kinzel S, Weber MS.
    Front Immunol; 2019 Sep 15; 10():201. PubMed ID: 30800132
    [Abstract] [Full Text] [Related]

  • 32. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
    Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S.
    Biochem Biophys Res Commun; 2009 Sep 04; 386(4):623-7. PubMed ID: 19545538
    [Abstract] [Full Text] [Related]

  • 33. Neuromyelitis optica: changing concepts.
    Jacob A, Matiello M, Wingerchuk DM, Lucchinetti CF, Pittock SJ, Weinshenker BG.
    J Neuroimmunol; 2007 Jul 04; 187(1-2):126-38. PubMed ID: 17512987
    [Abstract] [Full Text] [Related]

  • 34. Specificities of Children with Multiple Sclerosis and Neuromyelitis Optica.
    Fragoso YD.
    Cent Nerv Syst Agents Med Chem; 2018 Jan 26; 18(1):16-20. PubMed ID: 26654228
    [Abstract] [Full Text] [Related]

  • 35. Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies.
    Hino-Fukuyo N, Haginoya K, Nakashima I, Sato DK, Takahashi T, Misu T, Fujihara K, Hirose M, Kakisaka Y, Uematsu M, Kobayashi T, Kure S.
    Brain Dev; 2015 Oct 26; 37(9):849-52. PubMed ID: 25748628
    [Abstract] [Full Text] [Related]

  • 36. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis.
    Dale RC, Brilot F, Banwell B.
    Curr Opin Neurol; 2009 Jun 26; 22(3):233-40. PubMed ID: 19434783
    [Abstract] [Full Text] [Related]

  • 37. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes.
    Parratt JD, Prineas JW.
    Mult Scler; 2010 Oct 26; 16(10):1156-72. PubMed ID: 20823059
    [Abstract] [Full Text] [Related]

  • 38. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.
    Yanagawa K, Kawachi I, Toyoshima Y, Yokoseki A, Arakawa M, Hasegawa A, Ito T, Kojima N, Koike R, Tanaka K, Kosaka T, Tan CF, Kakita A, Okamoto K, Tsujita M, Sakimura K, Takahashi H, Nishizawa M.
    Neurology; 2009 Nov 17; 73(20):1628-37. PubMed ID: 19917985
    [Abstract] [Full Text] [Related]

  • 39. [Treatment and clinical management of patients with neuromyelitis optica and anti-aquaporin 4 antibody].
    Ochi H.
    Brain Nerve; 2010 Sep 17; 62(9):945-52. PubMed ID: 20844305
    [Abstract] [Full Text] [Related]

  • 40. Antibody-negative neuromyelitis optica with heavy B-cell infiltration.
    Blackburn D, Highley JR, Wharton S, Romanowski C, Bowen J, Sharrack B.
    APMIS; 2009 Oct 17; 117(10):768-72. PubMed ID: 19775346
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.